Abbonarsi

Blue-light imaging has an additional value to white-light endoscopy in visualization of early Barrett's neoplasia: an international multicenter cohort study - 21/03/19

Doi : 10.1016/j.gie.2018.10.046 
Albert J. de Groof, MD 1, Anne-Fré Swager, MD, PhD 1, Roos E. Pouw, MD, PhD 1, Bas L.A.M. Weusten, MD, PhD 1, 2, Erik J. Schoon, MD, PhD 3, Raf Bisschops, MD, PhD 4, Oliver Pech, MD, PhD 5, Alexander Meining, MD, PhD 6, Horst Neuhaus, MD, PhD 7, Wouter L. Curvers, MD, PhD 3, Jacques J.G.H.M. Bergman, MD, PhD 1,
1 Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands 
2 Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands 
3 Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands 
4 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium 
5 Gastroenterology and Interventional Endoscopy, Krankenhaus Barmherzige Brüder, Regensburg, Germany 
6 Center of Internal Medicine, Ulm University, Ulm, Germany 
7 Internal Medicine, Evangelisches Krankenhaus Düsseldorf, Düsseldorf, Germany 

Reprint requests: J.J. Bergman, MD, PhD, Professor of Gastrointestinal Endoscopy, Director of Endoscopy, Amsterdam UMC, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.Professor of Gastrointestinal Endoscopy, Director of Endoscopy, Amsterdam UMCAcademic Medical CenterMeibergdreef 9AZ Amsterdam1105the Netherlands

Abstract

Background and Aims

Endoscopic features of early neoplasia in Barrett's esophagus (BE) are subtle. Blue-light imaging (BLI) may improve visualization of neoplastic lesions. The aim of this study was to evaluate BLI in visualization of Barrett’s neoplasia.

Methods

Corresponding white-light endoscopy (WLE) and BLI images of 40 BE lesions were obtained prospectively and assessed by 6 international experts in 3 assessments. Each assessment consisted of overview and magnification images. Assessments were as follows: assessment 1, WLE only; assessment 2, BLI only; and assessment 3, corresponding WLE and BLI images. Outcome parameters were as follows: (1) appreciation of macroscopic appearance and surface relief (visual analog scale scores); (2) ability to delineate lesions (visual analog scale scores); (3) preferred technique for delineation (ordinal scores); and (4) quantitative agreement on delineations (AND/OR scores).

Results

Experts appreciated BLI significantly better than WLE for visualization of macroscopic appearance (median 8.0 vs 7.0, P < .001) and surface relief (8.0 vs 6.0, P < .001). For both overview and magnification images, experts appreciated BLI significantly better than WLE for ability to delineate lesions (8.0 vs 6.0, P < .001 and 8.0 vs 5.0, P < .001). There was no overall significant difference in AND/OR scores of WLE + BLI when compared with WLE, yet agreement increased significantly with WLE + BLI for cases with a low baseline AND/OR score on WLE, both in overview (mean difference, 0.15; P = .015) and magnification (mean difference, 0.10; P = .01).

Conclusions

BLI has additional value for visualization of BE neoplasia. Experts appreciated BLI better than WLE for visualization and delineation of BE neoplasia. Quantitative agreement increased significantly when BLI was offered next to WLE for lesions that were hard to delineate with WLE alone. (ISRCTN registry study ID: ISRCTN15916689.)

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : BE, BLI, EAC, VAS, WLE


Mappa


 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.


© 2019  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 89 - N° 4

P. 749-758 - aprile 2019 Ritorno al numero
Articolo precedente Articolo precedente
  • Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China
  • Xinying Yu, Sanne N. van Munster, Yueming Zhang, Liyan Xue, David E. Fleischer, Bas L.A.M. Weusten, Ning Lu, Sanford S.M. Dawsey, Jacques J.G.H.M. Bergman, Guiqi Wang
| Articolo seguente Articolo seguente
  • Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett’s esophagus
  • Hassan A. Siddiki, Dora M. Lam-Himlin, Allon Kahn, M. Veronica Bandres, George E. Burdick, Michael D. Crowell, Rahul Pannala, Francisco C. Ramirez, Marcelo F. Vela, David E. Fleischer

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.